GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 18, 2024
Displaying entries 37851 - 37900 of 40384 in total
PDB ID UniProt ID ▼ Title Descriptor
6CNJ 6CNJ Structure of the 2alpha3beta stiochiometry of the human Alpha4Beta2 nicotinic receptor Neuronal acetylcholine receptor subunit alpha-4,Neuronal acetylcholine receptor subunit beta-2,IgG1 Kappa Light Chain, IgG1 Heavy Chain
6CMX 6CMX Human Teneurin 2 extra-cellular region
6CMO 6CMO Rhodopsin-Gi complex
6CMI 6CMI Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3
6CMG 6CMG Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3
6CM3 6CM3 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CK9 6CK9 Crystal Structure of HIV-1 ConC_Base0 Prefusion Env Trimer in Complex with Human Antibody Fragment 3H109L and 35O22 variants at 3.5 Angstrom
6CJ9 6CJ9 Crystal structure of lectin from Dioclea lasiophylla seeds (DlyL) complexed with X-Man
6CH9 6CH9 Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22
6CH8 6CH8 Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22
6CH7 6CH7 XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain
6CE0 6CE0 Crystal structure of a HIV-1 clade B tier-3 isolate H078.14 UFO-BG Env trimer in complex with broadly neutralizing Fabs PGT124 and 35O22 at 4.6 Angstrom
6CDI 6CDI Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 VRC03 Heavy Chain, VRC03 light chain, PGT122 Heavy Chain, PGT122 Light Chain, Glycoprotein 120, Glycoprotein gp41, vFP16.02 Heavy Chain, vFP16.02 Light Chain
6CDE 6CDE Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain
6CCB 6CCB Crystal structure of 253-11 SOSIP trimer in complex with 10-1074 Fab
6CBP 6CBP Crystal structure of the single chain variable fragment of the DH270.6 bnAb in complex with the Man9-V3 glycopeptide
6CBJ 6CBJ Crystal Structure of DH270.3 Fab in complex with Man9
6CBJ 6CBJ Crystal Structure of DH270.3 Fab in complex with Man9
6C9W 6C9W Crystal Structure of a ligand bound LacY/Nanobody Complex
6C6Z 6C6Z Crystal structure of potent neutralizing antibody CDC2-C2 in complex with MERS-CoV S1 RBD
6C5V 6C5V An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus
6C5K 6C5K S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 2)
6C5K 6C5K S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 2)
6C5J 6C5J S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 1)
6C5J 6C5J S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 1)
6C5I 6C5I Unliganded S25-5 Fab
6C5I 6C5I Unliganded S25-5 Fab
6C5H 6C5H S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen
6C5H 6C5H S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen
6C09 6C09 Ternary crystal structure of the 3C8 TCR-CD1c-monoacylglycerol complex
6BZD 6BZD Structure of 14-3-3 gamma R57E mutant bound to GlcNAcylated peptide
6BYL 6BYL Structure of 14-3-3 gamma bound to O-GlcNAcylated thr peptide
6BYK 6BYK Structure of 14-3-3 beta/alpha bound to O-ClcNAc peptide
6BYJ 6BYJ Structure of human 14-3-3 gamma bound to O-GlcNAc peptide
6BXC 6BXC Crystal structure of N-terminal fragment of Zebrafish Toll-Like Receptor 5 (TLR5) with Lamprey Variable Lymphocyte Receptor 9 (VLR9) bound
6BXA 6BXA Crystal structure of N-terminal fragment of Zebrafish Toll-Like Receptor 5 (TLR5) with Lamprey Variable Lymphocyte Receptor 2 (VLR2) bound
6BX4 6BX4 The crystal structure of fluoride channel Fluc Ec2 with Monobody S9
6BWI 6BWI 3.7 angstrom cryoEM structure of full length human TRPM4
6BRB 6BRB Novel non-antibody protein scaffold targeting CD40L
6BP2 6BP2 Therapeutic human monoclonal antibody MR191 bound to a marburgvirus glycoprotein
6BNL 6BNL Crystal structure of TCR-MHC-like molecule
6BNK 6BNK Crystal structure of TCR-MHC-like molecule
6BMT 6BMT Crystal Structure of a Recombinant form of Human Myeloperoxidase Bound to an Inhibitor from Staphylococcus delphini
6BKD 6BKD Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D
6BKD 6BKD Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D
6BKC 6BKC Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B
6BKC 6BKC Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B
6BKB 6BKB Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A
6BKB 6BKB Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A
6BJ2 6BJ2 TCR589 in complex with HIV(Pol448-456)/HLA-B35

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024